By
Drug Target Review2025-02-04T08:00:04
A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides that can bind to and destroy previously untreatable proteins.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2024-02-06T08:57:06
Sponsored by bit.bio
Site powered by Webvision Cloud